Shares of HIMS experienced a dramatic decline today following the unexpected withdrawal of its deal with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending its stock price plummeting by nearly 20%. The reason for the dissolution of the partnership remains unclea